COVID-19 occurring during Natalizumab treatment: a case report in a patient with extended interval dosing approach
Author:
Publisher
Elsevier BV
Subject
Clinical Neurology,Neurology,General Medicine
Reference5 articles.
1. Extending the Interval of Natalizumab Dosing: Is Efficacy Preserved?;Clerico;Neurotherapeutics,2020
2. MS disease activity in RESTORE: a randomized 24-week natalizumab treatment interruption study;Fox;Neurology,2014
3. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet,2020
4. COVID-19-associated Acute Hemorrhagic Necrotizing Encephalopathy: CT and MRI Features;Poyiadji;Radiology,2020
5. A Novel Coronavirus from Patients with Pneumonia in China, 2019;Zhu;N Engl J Med,2020
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Flu-like syndrome due to interferon-beta injections does not increase anxiety, depression, and lost working days in multiple sclerosis patients during the Sars-CoV-2 pandemic;Clinical Neurology and Neurosurgery;2023-09
2. Immune responses following COVID-19 infection in multiple sclerosis patients using immunomodulatory therapy;Acta Neurologica Belgica;2022-11-04
3. Mental Health in Multiple Sclerosis During the COVID-19 Outbreak: A Delicate Balance between Fear of Contagion and Resilience;Journal of Clinical Psychology in Medical Settings;2022-01-22
4. Drugs Used in the Treatment of Multiple Sclerosis During COVID-19 Pandemic: A Critical Viewpoint;Current Neuropharmacology;2022-01
5. Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series;BMC Neurology;2021-11-29
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3